Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Comparision between CWD Limited IPO and Nidan Laboratories and Healthcare IPO.
CWD Limited IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while Nidan Laboratories and Healthcare IPO is a SME Fixed Price Issue proposed to list at NSE SME.
| CWD Limited IPO | Nidan Laboratories and Healthcare IPO | |
|---|---|---|
| Logo |  |
 |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price Issue | Fixed Price Issue |
| Listing At | BSE SME | NSE SME |
| Lead Managers | Aryaman Financial Services Limited | First Overseas Capital Limited |
| Registrar | Kfin Technologies Limited | Bigshare Services Pvt Ltd |
| Market Maker | ||
| DRHP | DRHP  |
DRHP |
| RHP | RHP |
RHP |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL |
The total issue size of CWD Limited IPO is up to ₹18.01 Cr whereas the issue size of the Nidan Laboratories and Healthcare IPO is up to ₹50.00 Cr. The final issue price of CWD Limited IPO is ₹180.00 per share and of Nidan Laboratories and Healthcare IPO is ₹125.00 per share.
| CWD Limited IPO | Nidan Laboratories and Healthcare IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹180.00 per share | ₹125.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 800 shares | 1000 shares |
| Fresh Issue Size | 8,50,800 shares | |
| Fresh Issue Size (Amount) | up to ₹15.31 Cr | |
| OFS Issue Size | 1,50,000 shares | |
| OFS Issue Size (Amount) | up to ₹2.70 Cr | |
| Issue Size Total | 10,00,800 shares | 40,00,000 shares |
| Issue Size Total (Amount) | up to ₹18.01 Cr | up to ₹50.00 Cr |
CWD Limited IPO opens on Sep 30, 2021, while Nidan Laboratories and Healthcare IPO opens on Oct 28, 2021. The closing date of CWD Limited IPO and Nidan Laboratories and Healthcare IPO is Oct 05, 2021, and Nov 02, 2021, respectively.
| CWD Limited IPO | Nidan Laboratories and Healthcare IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Sep 30, 2021 | Oct 28, 2021 |
| Issue Close | Oct 05, 2021 | Nov 02, 2021 |
| Basis Of Allotment (Tentative) | Oct 08, 2021 | Nov 09, 2021 |
| Initiation of Refunds (Tentative) | Oct 11, 2021 | Nov 10, 2021 |
| Credit of Share (Tentative) | Oct 12, 2021 | Nov 11, 2021 |
| Listing date (Tentative) | Oct 13, 2021 | Nov 12, 2021 |
| Anchor Lockin End date 1 | Nov 07, 2021 | Dec 09, 2021 |
| Anchor Lockin End date 2 | Jan 06, 2022 | Feb 07, 2022 |
CWD Limited IPO P/E ratio is , as compared to Nidan Laboratories and Healthcare IPO P/E ratio of .
| CWD Limited IPO | Nidan Laboratories and Healthcare IPO | |||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 100.00% | 99.99% | ||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 72.29% | 71.22% | ||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||
| ROE | ||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | ||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | ||||||||||||||||||||||||||||||||||||||||||||||
In the CWD Limited IPO retail investors (RII) are offered 4,75,200 shares while in Nidan Laboratories and Healthcare IPO retail investors are offered 4,75,200 shares. Qualified institutional buyers (QIB) are offered in CWD Limited IPO and in Nidan Laboratories and Healthcare IPO.
| CWD Limited IPO | Nidan Laboratories and Healthcare IPO | |
|---|---|---|
| Anchor Investor Reserveration | ||
| Market Maker Reserveration | 50,400 shares | 2,00,000 shares |
| QIB | ||
| NII | 4,75,200 shares | 19,00,000 shares |
| RII | 4,75,200 shares | 19,00,000 shares |
| Employee | ||
| Others | ||
| Total | 9,50,400 shares | 38,00,000 shares |
CWD Limited IPO subscribed 1.31x in total, whereas Nidan Laboratories and Healthcare IPO subscribed 1.80x.
| CWD Limited IPO | Nidan Laboratories and Healthcare IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 1.91x | 0.15x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 0.71x | 3.44x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 1.31x | 1.80x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
